Cumberland Pharmaceuticals Inc. Operating Lease Right-of-Use Assets
Cumberland Pharmaceuticals Inc. (CPIX) had Operating Lease Right-of-Use Assets of $7.28 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2026-08-07
- 2026-06-30: Operating Lease, Right-of-Use Asset $7.28M.
- 2026-03-31: Operating Lease, Right-of-Use Asset $7.62M.
- 2025-12-31: Operating Lease, Right-of-Use Asset $5.78M; Operating Lease, Right-of-Use Asset as first filed $8.34M.
- 2025-09-30: Operating Lease, Right-of-Use Asset $7.57M.
| Period end | Operating Lease, Right-of-Use Asset | Operating Lease, Right-of-Use Asset as first filed |
|---|---|---|
| 2026-06-30 | $7.28M 10-Q · filed 2026-08-07 | |
| 2026-03-31 | $7.62M 10-Q · filed 2026-05-08 | |
| 2025-12-31 | $5.78M 10-Q · filed 2026-08-07 | $8.34M 10-K · filed 2026-03-09 |
| 2025-09-30 | $7.57M 10-Q · filed 2025-11-07 | |
| 2025-06-30 | $7.13M 10-Q · filed 2025-08-08 | |
| 2025-03-31 | $7.18M 10-Q · filed 2025-05-09 | |
| 2024-12-31 | $6.18M 10-K · filed 2026-03-09 | |
| 2024-09-30 | $6.21M 10-Q · filed 2024-11-08 | |
| 2024-06-30 | $6.37M 10-Q · filed 2024-08-09 | |
| 2024-03-31 | $6.52M 10-Q · filed 2024-05-10 | |
| 2023-12-31 | $6.67M 10-K · filed 2025-03-07 | |
| 2023-09-30 | $6.71M 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $6.83M 10-Q · filed 2023-08-11 | |
| 2023-03-31 | $4.92M 10-Q · filed 2023-05-12 | |
| 2022-12-31 | $5.22M 10-K · filed 2024-03-13 | |
| 2022-09-30 | $219.85K 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $493.10K 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $761.18K 10-Q · filed 2022-05-13 | |
| 2021-12-31 | $1.02M 10-K · filed 2023-03-13 | |
| 2021-09-30 | $1.28M 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $1.54M 10-Q · filed 2021-08-13 | |
| 2021-03-31 | $1.78M 10-Q · filed 2021-05-14 | |
| 2020-12-31 | $2.03M 10-K · filed 2022-03-11 | |
| 2020-09-30 | $2.27M 10-Q · filed 2020-11-13 | |
| 2020-06-30 | $2.50M 10-Q · filed 2020-08-14 | |
| 2020-03-31 | $2.73M 10-Q · filed 2020-05-22 | |
| 2019-12-31 | $2.96M 10-K · filed 2021-03-12 | |
| 2019-09-30 | $3.05M 10-Q · filed 2019-11-13 | |
| 2019-06-30 | $3.26M 10-Q · filed 2019-08-14 | |
| 2019-03-31 | $3.49M 10-Q · filed 2019-05-15 | |
| 2019-01-01 | $3.60 10-K · filed 2021-03-12 | $3.60M 10-Q · filed 2019-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |